US Food and Drug Administration awards Critical Path Institute 3 grants, 1 contract

The US Food and Drug Administration (FDA) has awarded Critical Path Institute (C-Path) three grants to develop data standards, as well as a contract to continue its research into drug-induced kidney injury. With these awards, the FDA continues to support C‑Path’s efforts to advance translational research toward accelerating drug development and regulatory review.Continue reading

To Treat the Heart, Neurotechnology Aims to Balance the Brain

Brain State Technologies (Scottsdale, Arizona) has  announced that use of their allostatic neurotechnology was associated with positive effects for the cardiovascular system and reduction of inflammation, in individuals with diverse health conditions. The findings are being presented at the Council on Hypertension of the American Heart Association, meeting in Orlando, Florida from September 14-17.Continue reading